Lv56
810 积分 2024-08-10 加入
Interleukin-17 in Liver Disease Pathogenesis
2天前
已完结
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
7天前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
24天前
已完结
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
1个月前
已完结
Hepatic danger signaling triggers TREM2+ macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
1个月前
已完结
FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond
1个月前
已完结
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis
1个月前
已完结
Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments
1个月前
已完结
The Role of the Gut Microbiome in the Development and Progression of Type 2 Diabetes and Liver Disease
3个月前
已完结
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
3个月前
已完结
皖公网安备34019202002308
